• GRA12’s Conserved Virulence Role in Toxoplasma gondii: In Vi

  2026-05-25

  A recent in vivo CRISPR screen has identified GRA12 as a secreted virulence factor essential for Toxoplasma gondii infection across diverse parasite lineages and mouse subspecies. This work advances our understanding of pan-strain immune evasion, providing new avenues to dissect conserved host-pathogen interactions in apicomplexan parasites.

• Nanospike-Induced Mechanical Stress Drives Autophagic Cell D

  2026-05-24

  A recent study demonstrates that engineered gold nanospikes induce lethal autophagy in cancer cells by generating lysosomal membrane stress, revealing a direct mechanobiological pathway for tumor inhibition. These findings advance the understanding of intracellular mechanical signaling and open new avenues for precision cancer therapies targeting autophagy.

• Perifosine (KRX-0401): Apoptosis Pathways and Clinical Persp

  2026-05-23

  Explore how Perifosine, a synthetic Akt inhibitor, induces apoptosis and enhances radiosensitization in cancer cells. This article provides a deep dive into its mechanism, the latest signaling pathway insights, and unique applications beyond standard protocols.

• Sabutoclax: Applied Protocols for Pan-Bcl-2 Inhibitor Assays

  2026-05-22

  Sabutoclax is redefining apoptosis induction with its robust pan-Bcl-2 inhibition, precise selectivity, and superior cell permeability. This article delivers actionable workflows and troubleshooting guidance for maximizing Sabutoclax-driven cancer cell assays, informed by leading-edge in vitro methodologies and real-world lab scenarios.

• Sadoamides A and B: Novel Proteasome Inhibitors from Strepto

  2026-05-22

  Park et al. report the discovery of sadoamides A and B, two unique tripeptides from Streptomyces sp. YNK18 incorporating nonproteinogenic amino acids. These compounds selectively inhibit proteasome activity, modulate apoptosis, and highlight new bacterial strategies for regulating eukaryotic cell fate, with implications for chemical biology and cancer research.

• OM-MSCs Mitigate GA Stress via PEDF-PI3K/Akt/mTOR in Stroke

  2026-05-21

  The referenced study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus (GA) stress responses following cerebral ischemia/reperfusion injury through activation of the PEDF-PI3K/Akt/mTOR signaling pathway. This work advances mechanistic understanding of neuroprotection after stroke and highlights the intersection of stem cell therapy with molecular signaling modulation.

• Exploiting BCL-XL/MCL-1 Dependence in Glioblastoma with BH3-

  2026-05-21

  The referenced study demonstrates that glioblastoma (GBM) cells, especially stem-like subpopulations, exhibit elevated anti-apoptotic BCL-XL and MCL-1 expression, creating a vulnerability to BH3-mimetic drugs. Sequential inhibition of these proteins induces robust apoptosis in GBM models, highlighting a promising therapeutic avenue for overcoming resistance in this aggressive cancer.

• Cyclophosphamide: Protocol Optimization for Cancer Research

  2026-05-20

  Cyclophosphamide is a gold-standard alkylating chemotherapeutic agent, prized for its dual role in apoptosis induction and immunomodulation. This guide unpacks advanced workflows, troubleshooting strategies, and key innovations to maximize experimental reproducibility and translational relevance in oncology and immunology research.

• Sabutoclax (SKU A4199): Reliable Pan-Bcl-2 Inhibition in Can

  2026-05-20

  This article provides evidence-based guidance for deploying Sabutoclax (SKU A4199), a pan-Bcl-2 inhibitor, in apoptosis and cell viability workflows. Addressing real lab challenges with data-driven Q&A, it highlights Sabutoclax’s reproducibility, potency, and vendor reliability for cancer research applications.

• Primidone (Mysoline) and Human Serum Paraoxonase-1 Inhibitio

  2026-05-19

  This study provides a quantitative analysis of how Primidone (Mysoline) and other antiepileptic drugs inhibit human serum paraoxonase-1 (hPON1) activity in vitro. The findings illuminate mechanistic interactions relevant for both clinical therapy and translational disease model research.

• E. coli Uracil-DNA Glycosylase (UDG): Technical Use & QC Gui

  2026-05-19

  E. coli Uracil-DNA Glycosylase (UDG) is designed to excise uracil from DNA, preventing PCR product contamination and supporting high-fidelity DNA amplification. Use this enzyme strictly for research workflows involving DNA, not for RNA, short oligonucleotides, or diagnostic applications.

• SM-164 (SKU A8815): Reliable Bivalent Smac Mimetic for Cance

  2026-05-18

  This article presents an evidence-based, scenario-driven analysis of SM-164 (SKU A8815), a bivalent Smac mimetic from APExBIO, addressing key laboratory challenges in apoptosis and cytotoxicity workflows. Drawing on literature and product data, it details how SM-164 enables reproducible, sensitive apoptosis induction in tumor cell models, supporting reliable caspase activation assays and advanced cancer research.

• Topotecan’s Role in Cancer Therapy: Pharmacology and Clinica

  2026-05-18

  The reference review details topotecan’s innovation as a water-soluble topoisomerase I inhibitor, highlighting its pharmacological features, clinical efficacy in refractory cancers, and safety profile. Its unique mechanism and non-cross-resistance underpin its value in combination regimens, while also informing translational research involving DNA-targeting chemotherapeutics.

• Chenodeoxycholic Acid: FXR-KLF11 Modulation and Translationa

  2026-05-17

  Explore the unique mechanistic insights of Chenodeoxycholic Acid (CDCA) in FXR-KLF11 pathway modulation. This article delivers an advanced, practical perspective on CDCA’s role in cholesterol metabolism research and renal protection, bridging molecular detail with translational assay implications.

• RNA Pol II Degradation Triggers Active Apoptosis in Cancer C

  2026-05-16

  Harper et al. (2025) reveal that inhibition of RNA polymerase II (Pol II) induces apoptosis through a regulated pathway independent of transcriptional loss. This discovery uncovers a distinct cell death mechanism, informing both mechanistic cancer research and the strategic use of apoptosis inducers such as bivalent Smac mimetics.

16669 records 1/1112 page Next 12345 下5页 Last page